METHOD AND SYSTEM FOR CULTIVATING CELLS PARTICULARLY MACROPHAGES

Abstract: A method of cultivating cells present in suspension by placing the cells, one or more reagents, and a culture medium in separate sterile containers connected together and hermetically sealed by sterile tubings having fluid flow control devices which may be manually opened and closed, and opening and closing the fluid flow control devices as required in order to transfer the contents of one container to another, while isolating the container contents from the external environment. The method is particularly useful for cultivating macrophages in a completely controlled atmosphere hermetically sealed from the outside atmosphere.

Description: METHOD AND SYSTEM FOR CULTIVATING CELLS PARTICULARLY MACROPHAGES The present invention relates to a method and system for cultivating cells. The method and system are particularly useful for growing macrophages from human blood, and are therefore described below with respect to this application. Macrophages, namely phagocytic cells phagocytize and digest old and deteriorated red blood cells, bacteria and other microscopic particles. They have been found to play an important role in wound repair. They produce substances that stimulate proliferation of fibroblasts, the synthesis of collagen by fibroblasts, and other elements that are necessary for wound healing. For example, it was found that wound repair could be accelerated in old mice by application of the wounds of macrophages derived from peritoneal fluids of young mice (D. Danon, M.A. Kowatch and G.S. Roth, Proc. Natl. Acad. Sci. USA, Vol.86, pp.2018-2020, March 1989) . The present methods of preparing macrophages out of blood monocytes are complicated, expensive, time- consuming and difficult to apply routinely, because they require considerable specialized labour, expensive disposable materials, and specialized laboratory facilities. Moreover, the present techniques involve a significant risk of contamination during preparation and therefore require regular testing to assure the absence of bacterial infection in the resulting suspension of macrophages. An object of the present invention is to provide a method and system for growing cells, particularly, macrophages, which have advantages in the above respects. More particularly, an object of the invention is to provide a method and system for growing cells, particularly macrophages, which do not require specialized labour, expensive disposable materials, or a specialized laboratory, and which reduce considerably the risk of infection. According to one aspect of the present invention, there is provided a method of cultivating cells present in suspension by subjecting the cells to at least one sterile reagent and cultivating the cells in a sterile culture medium, comprising: placing the cells in suspension, the at least one reagent, and the culture medium in three separate sterile containers; connecting together the containers, and hermetically sealing their contents from the atmosphere, by sterile tubings having fluid flow control devices which may be opened and closed; and opening and closing the fluid flow control devices as required in order to transfer the contents of one container to another, while isolating the container contents from the external environment. The invention is particularly useful for cultivating macrophages from blood. Since the complete process can thus be carried out in a completely controlled atmosphere hermetically sealed from the outside atmosphere, there is little risk of infection, and therefore no need for special sterile hoods, laminary flows, and sterile disposable tools. Testing to assure the absence of bacterial infection is not crucial. In fact, not one case of infection was found in 150 preparations of macrophages in accordance with the method of the present invention where every second or third preparation was tested. According to another aspect of the present invention, there is provided a method of cultivating macrophages, comprising: separating from an initial quantity of blood, a white blood cell fraction which includes a mixture of all kinds of white blood cells and red blood cells having usually a much higher concentration of white blood cells than in the initial quantity of blood; subjecting the white blood cell fraction (buffy coat) to an osmotic shock which is more destructive of red blood cells than white blood cells; re-establishing iso-tonicity in the white blood cell fraction; adding the white blood cell fraction to a culture medium in a container; and incubating the culture medium with the white blood cells fraction. It has been found that subjecting the white blood cell fraction to osmotic shock and then re-establishing iso- tonicity therein destroys substantially all the red blood cells and much fewer white blood cells, such that the result is a suspension having a high concentration of white blood cells suitable for cultivation in a container with a culture medium. It has also been found that this osmotic shock treatment of the monocytes in the white blood cells fraction enhances their differentiation into macrophages, as evidenced morphologically. Preferably, the white cell fraction is subjected to osmotic shock by mixing it with a 15-fold volume of distilled water for a period of 30-90 seconds; a period of 60 seconds has been found particularly effective. The iso-tonicity is also preferably re-established by adding to the white blood cell fraction a hypertonic solution of one tenth of the volume of the distilled water used and ten times the concentration of iso-tonic solution, preferably a 9% solution of NaCl. According to a further important feature of the invention, a serum prepared from the initial quantity of blood is added to the separated white blood cells in the culture medium. This serum is prepared by separating a desired volume of a plasma from the initial quantity of blood, adding a coagulating agent to the plasma to produce the serum, and then separating the serum from the coagulated plasma. Prior procedures for preparing macrophages introduced fetal calf serum or pooled human serum but there is a danger that fetal calf serum may cause creation of antibodies against this serum in the treated host, and pooled human serum increases the probability of adding the danger of viral infection. These dangers are avoided by using serum prepared from the same blood from which the white blood cells were separated. According to a still further aspect of the present invention, there is provided apparatus for cultivating cells present in suspension by subjecting the cells to at least one sterile reagent and cultivating the cell in a sterile culture medium, comprising: a first container for receiving the cells in suspension; a second container for receiving the at least one reagent; and a third container for receiving the culture medium; the containers being connected together and hermetically sealed from the atmosphere by sterile tubings having fluid flow control devices which may be opened and closes at required in order to transfer the contents of one container to another, while isolating the container contents from the external environment. While it was previously known, as indicated above, that wound repair could be accelerated in old mice by application to their wounds of macrophages derived from peritoneal fluids of young mice, insofar as the applicant is aware it was not known to use macrophages derived from blood for the therapeutic treatment of a living body, and particularly for wound healing. According to a still further aspect of the present invention, therefore, there is provided a method for the therapeutic treatment of a living body by applying thereto macrophages cultivated from blood. Further features and advantages of the invention will be apparent from the description below of a specific example of a method of growing macrophages in accordance with the present invention, using a system as illustrsted in the single accompanying drawing figure. The following example describes a procedure for growing macrophages out of white blood cells contained in a quantity of human blood as obtained from the blood bank. The described procedure is carried out in a totally enclosed system without exposing the cells or the various media involved in the procedure to the external environment. Before the procedure is started, the system illustrated in the drawing is setup by providing the following containers in the form of flexible plastic bags PB..-PB 8 : plastic bag PB 1 , for containing the initial quantity of blood to be processed; plastic bags PB, and B 3 , for receiving a plasma fraction and a white blood cell fraction, respectively, separated from the initial quantity of blood in plastic bag PB-. during the procedure; plastic bags PB., PB 5 and PB β for receiving distilled water (150 ml), a 9% solution of NaCl (15 ml), and CaCl-,, respectively, used as reagents during the procedure; and plastic bag PB 7 , to contain a culture medium to be used in the procedure. If desired, an eighth plastic bag PB β may be included also to contain a culture medium. Preferably, plastic bags PB_ and/or PB β contains an injection port IP (shown only in plastic bag PB_) for injecting one or more additives to the culture medium within that bag, as will be described more particularly below. All the plastic bags PB..-PB 8 are interconnected together by tubings generally designated 2, which hermetically seal the contents of each bag from the atomosphere. The illustrated tubings 2 include a plurality of manual valves, in the form of slide clamps SC--SC 10 , which may be manually closed in order to seal the contents of each bag from the others, or manually opened in order to permit transfer of the contents of one bag to another during the various stages of the procedure. It will thus be seen that the illustrated system of plastic bags PB_,-PB β , interconnected together by tubings 2 having the slide clamps SC.-SC 10 , isolate all the container contents from the external environment while permitting transfer of the contents of one container to another during the various stages of the procedure. A quantity of human blood is first collected into bag PB- (containing an anti-coagulant) by venipuncture in the blood bank using a sterile needle 4. Bags PB 2 and PB-. are initially empty. The three bags PB- , PB, and PB-. are introduced into one container of a centrifuge, while the remaining bags PB.-PB 8 are introduced into the opposite container of the centrifuge, with all the bags being connected together by tubing 2 and all the slide clamps CC,-CC Q closed. The two centrifuge containers are equilibrated. The bags are centrifuged for five minutes at 2,500 rpm (1,000g). This causes the blood within plastic bag PB.. to separate into a plasma fraction, a white blood cell (buffy coat) fraction, and a red blood cell fraction. The plasma fraction is transferred into bag PB, after opening slide clamps SC. and SC- and compressing bag PB- . Then the white blood cell fraction is transferred to bag PB-. after opening slide clamps SC. , SC., and SC.,. At this stage, a part of the plasma fraction is returned to the red blood cell fraction in plastic bag PB- after opening slide clamps SC-., SC. and SC.. Bag PB.. may then be disconnected near slide clamp SC. (after sealing the plastic tubing) and returned to the blood bank for use. The white blood cell fraction now in bag PB- is a mixture of white blood cells with red blood cells, but having a higher concentration of white blood cells than in the initial quantity of blood. The white blood cell fraction now in bag PB, is subjected to an osmotic shock which is more destructive (shock lysis) of the red blood cells than the white blood cells in that bag. This is done by transferring the distilled water (150 ml) in bag PB. to bag PB-., by opening slide clamps SC g , SC- and SC-,. This should be executed as quickly as possible, by placing bag PB 3 flat on a table, with one hand pressing bag PB. to discharge the water from that bag into bag PB 3 , and using the other hand for mixing the water with the white blood cell fraction in bag PB-.. This mixing is done for a period of between 30 to 90 seconds, best results having been obtained when it is done for 35 seconds. As indicated above, this subjects the white blood cell fraction within bag PB 3 to osmotic shock, destroying most of the red blood cells by shock lysis, thereby substantially increasing the concentration of the white blood cells within that bag. At this point, i.e., after the distilled water has been mixed with the white blood cell fraction in bag PB 3 for exactly 35 seconds, the 9% NaCl solution in bag PB 5 is introduced into plastic PB 3 , by opening slide clamps SC-, SC 5 and SC-., and closing slide clamp SC β and squeezing bag PB 5 to discharge its contents into bag PB-. The NaCl solution thus introduced into bag PB 3 , being a hypertonic solution, re-establishes iso-tonicity in the white blood cell fraction in bag B 3 . At this time, the 12 ml of 20mM CaCl- solution in bag PB, is transferred to the plasma fraction in bag PB-, by opening slide clamps SC g , SC 5 , SC- and SC,; all the other clamps are closed. The CaCl-, an agent enabling coagulation, starts the coagulation of the plasma. The plasma fraction in PB- may then be placed into a deep freezer, while the rest of the bags hang outside, for ten minutes and then removed. This procedure causes the permeation of the blood platelets with respect to the membranes, and the release of the platelet-derived growth factors. The plasma bag is now placed in a 37°C water bath for 30 minutes to complete the coagulation. If the coagulation is not complete by this time, which would be apparent from the appearance of the contents of the bag, the bag is returned to the 37°C water bath until coagulation is completed. Slide clamps SC_ and SC β are then closed, and bags PB 5 and PB, may then be removed after sealing the plastic tubing near the clamps. The bag system is then centrifuged at 1,500 rpm (580g) for five minutes. This sediments the coagulated part of the plasma in bag PB_, leaving the serum as supernatant. It also sediments the white blood cells in bag PB,. The supernatant liquid in the latter bag is transferred to bag PB., by opening slide clamps SC 3 , SC 5 and SC,. Bag PB., which originally contained the distilled water, now serves as a sink for receiving the shock lysed cells and the hemolysate in the liquid transferred from bag PB,, whereas the white blood cells and the few red blood cells that resisted the osmotic shock remain in bag PB,. The culture medium in bag PB- is now transferred to bag PB 3 , by opening slide clamps SC g , SC 5 and SC 3 to resuspend the white blood cells in bag PB-.. Cell aggregates are dispersed by manipulating bag PB 3 , and the suspension is then transferred back to the culture bag PB-,. The serum in bag PB- separated by the centrifugation is introduced into the liquid culture medium in bag PB- in an amount constituting 10-100% of the volume of the culture medium. Preferably, the culture medium is RPMI (Rosewell Park Memorial Institute). If e.g., 60 ml of RPMI is in the culture bag PB-,, approximately 6 ml of serum is added to that bag from the plasma bag PB-. This is done by opening slide clamps SC-, SC., SC- and SC„. At this stage bags, PB- and PB-. can be disconnected by sealing the plastic tubing near slide clamp SC g . The injection port IP of culture medium bag PB_ is then cleaned with ethanol, and an antibiotic mixture of penicillin plus streptomycin including buffer (hepes), is injected by means of a 5 ml syringe with an 18G needle via the injection port IP. The syringe is removed, but the needle is retained in the injection port IP and is used for injecting sterilized air into bag PB-, by means of an inflating pump that injects the air through an 0.2 micron pore filter, until the bag reaches a thickness of about 3 cm to 4 cm. The foregoing procedure up to this point usually takes about three hours. The culture bag is then introduced into a 37°C incubator and retained there for at least ten hours, preferably about 20 hours. After incubation, the supernatant of the culture bag PB- is transferred into the empty plastic bag PB., serving as a sink. The culture bag PB- now contains substantially only the adherent cells. These are the white blood cells or monocytes, that have already acquired morphological characteristics of macrophages, e.g., spindle- shape cells, triangular cells and pseudopods protruding from cells. About 10 ml of fresh culture medium at 37°C is then introduced from culture bag PB- into culture bag PB_, and the adherent cells in the latter bag are gently rinsed by tilting the bag several times to detach cells that are sedimented but not adherent. This rinsing liquid is then transferred into the "sink" bag PB.. The rinsing procedure is repeated. The number of macrophages that are adherent to the inner surface of the plastic bag PB- are estimated under an inverted microscope (objective 20, occular 15). At this magnification, the number of macrophages in the bag is equivalent to about 40,000 times the number of macrophages observed within the microscope field (i.e., there are about 40,000 microscope fields on the internal surface of the bag PB-, in this particular case). Thus, if the field contains 400 macrophages for example, it can be estimated that there would be about sixteen million macrophages within the bag. The rinsing fluid is now transferred to bag PB.. If it is desired to have about two million macrophages per ml, about 8 ml of RPMI would be transferred to bag PB_ from bag PB-. At this stage, the culture bag PB- is applied to a metallic cold plate at a temperature of about 4°C. This causes the adherent macrophages to detach from the inner surface of bag PB_. In order to accelerate the detachment of the macrophages, a glass plate is applied over the bag to sandwich the bag between the glass plate and the cold plate while the two plates, and the bag in between, are tilted back and forth several times to produce a mechanical agitation of the liquid within the bag. This procedure takes about 30 minutes. The cells can now be removed from the bag by using a disposable sterile syringe and needle via the injection port IP. A few drops may be used for counting the macrophages, and according to the results, the macrophages may be concentrated if desired by centrifugation in a sterile, disposable test tube. While the above procedure describes one example of a method for making macrophages from human blood, it will be appreciated that many variations may be made. For example, hypertonic solutions other than NaCl, coagulating agents other than CaCl-, and liquid culture media other than RPMI, may be used. Also, other techniques could be used for the initial separation of the white blood cells, e.g., by filtration or by leucophoresis. Further, it was found that if during the incubation period (at least ten hours, preferably 20-24 hours) at 37°C, if the temperature is raised to 41°C for at least one hour (preferably 1.5 hours) during the early part of the incubation period, a "heat shock" was produced which accelerated the differentiation of the monocytes into macrophages. Another variation would to be include a mixture of 5% CO- in the sterilized air introduced into the culture bag, instead of simple air. Also, the bag system may be made up of bag sub-systems connected together as necessary by a Sterile Connection Device. For example, the blood collection system PB--PB 3 may be connected to the macrophage processing system of bags PB.-PB- after separation of the while cells in bag PB-. and disconnection of red cell bag PB 1 . Further, while the invention has been found particularly useful for making macrophages, it will be appreciated that the technique and system using containers, tubings and slide clamps which permit the contents of the various containers to be transferred as desired in a closed hermetically-sealed system, may be advantageously used for cultivating other types of cells without danger of infection from the external atmosphere. The tubings used can be connected together by conventional connectors, such as rosettes or other multiple-port connectors. Still further, certain aspects of the invention can be used independently of other aspects. For example, the method of growing macrophages by the above-described, self-serum and closed-system technique could use other techniques than osmotic shock (e.g., hypertonic exposure, heavy metals, etc.) for inducing differentiation of the monocytes into macrophages. The invention could also be used for growing other types of cells than macrophages. Many other variations, modifications and applications of the invention will be apparent.

Claims: CLAIMS 1. A method of cultivating cells present in suspension by subjecting said cells to at least one sterile reagent and cultivating the cells in a sterile culture medium, comprising: placing said cells, said at least one reagent, and said culture medium in three separate sterile containers; connecting together said containers, and hermetically sealing their contents from the atmosphere, by sterile tubings having fluid flow control devices which may be opened and closed; and opening and closing said fluid flow control devices as required in order to transfer the contents of one container to another, while isolating the container contents from the external environment. 2. The method according to Claim 1 , wherein said cells are macrophages cultivated from blood. 3. The method according to Claim 2, wherein said macrophages are cultivated by: separating from an initial quantity of blood in said first container, a white blood cell fraction which includes a mixture of white blood cells and red blood cells having a higher concentration of white blood cells than in the initial quantity of blood; subjecting said white blood cell fraction to a reagent in said second container which produces an osmotic shock which is more destructive of red blood cells than white blood cells; re-establishing iso-tonicity in said white blood cell fraction; adding said white blood cell fraction to a culture medium in said third container; and incubating said culture medium. 4. The method according to Claim 3, wherein said white blood cell fraction is separated into a fourth container, and said iso-tonicity in said white blood cell fraction is re-established by introducing a hypertonic solution from a fifth container into the white blood fraction in said fourth container, all said containers being connected together by sterile tubings having fluid flow control devices. 5. The method according to Claim 4, wherein serum from said initial quantity of blood is added to said white blood cell fraction after iso-tonicity has been re-established and before the white blood cell fraction has been incubated in a culture medium. 6. The method according to Claim 5, wherein said serum is prepared by separating from said initial quantity of blood also a plasma fraction, adding an agent enabling coagulation to said plasma fraction from a sixth container to produce said serum, and separating said serum from the coagulated plasma. 7. The method according to any one of Claims 1-6, wherein all said containers are flexible plastic bags, and said fluid flow control devices are slide clamps. 8. A method of cultivating macrophages, comprising: separating from an initial quantity of blood, a white blood cell fraction which includes a mixture of white blood cells and red blood cells having a higher concentration of white blood cells than in the initial quantity of blood; subjecting said white blood cell fraction to an osmotic shock which is more destructive of red blood cells than white blood cells; re-establishing iso-tonicity in said white blood cell fraction; adding said white blood cell fraction to a culture medium; and incubating said culture medium. 9. The method according to Claim 8, wherein said white blood cell fraction is subjected to osmotic shock by mixing it with distilled water for a period of 30-90 seconds. 10. The method according to either of Claims 8 or 9, wherein iso-tonicity is re-established in said white blood cell fraction by adding a hypertonic solution thereto. 11. The method according to any one of Claims 8-10, wherein serum prepared from said initial quantity of blood is added to said white blood cell fraction after iso-tonicity has been re-established and before the white blood cell fraction has been incubated in a culture medium. 12. The method according to Claim 11 , wherein said serum is prepared by separating from said initial quantity of blood also a plasma fraction, adding a coagulating agent to said plasma fraction to produce said serum, and separating said serum from the coagulated plasma. 13. The method according to any one of Claims 8-12, wherein the white blood cell fraction and culture medium are incubated in a container, and said container after incubation is placed in contact with a cold plate tending to detach macrophages from the inner surface of the container. 14. The method according to any one of Claims 8-13, wherein the initial quantity of blood, each fraction separated therefrom, and each reagent used in the method, is contained in a separate container, which containers are all connected together and hermetically sealed from the atmosphere by tubings having clamps which may be manually opened and closed in order to permit transfer of the contents of one container to another to thereby isolate all the contents of the containers from the external environment. 15. The method according to Claim 14, wherein said containers are all flexible plastic bags, said tubings of flexible plastic tubes, and said clamps are slide clamps. 16. A method of growing macrophages, comprising: separating white blood cells from an initial quantity of blood; preparing a serum from said initial quantity of blood; adding said white blood cells and serum to a culture medium; and incubating said culture medium. 17. The method according to Claim 16, wherein said serum is prepared by separating from said initial quantity of blood also a plasma fraction, adding a coagulating agent to said plasma fraction to produce said serum, and separating said serum from the coagulated plasma. 18. The method according to Claim 17, wherein said white blood cells are separated from said initial quantity of blood by: separating from said initial quantity of blood a white blood cell fraction which includes a mixture of white blood cells and red blood cells having a higher concentration of white blood cells than in the initial quantity of blood; subjecting said white blood cell fraction to an osmotic shock more destructive of red blood cells than white blood cells; and re-establishing iso-tonicity in said white blood cell fraction. 19. The method according to either of Claims 17 or 18, wherein said white blood cells are separated in a first container, said plasma is separated in a second container, and said culture medium is in a third container; all said containers being connected together and hermetically sealed from the atmosphere by tubings having clamps which may be manually opened and closed in order to permit transfer of the contents of one container to another to thereby isolate all the contents of the containers from the external environment. 20. The method according to Claim 19, wherein said containers are all flexible plastic bags, said tubings are flexible plastic tubes, and said clamps are slide clamps. 21. Apparatus for cultivating cells present in suspension by subjecting said cells to at least one sterile reagent and cultivating the cell in a sterile culture medium, comprising: a first container for receiving said cells in suspension; a second container for receiving said at least one reagent; and a third container for receiving said culture medium; said containers being connected together and hermetically sealed from the atmosphere by sterile tubings having fluid flow control devices which may be opened and closes at required in order to transfer the contents of one container to another, while isolating the container contents from the external environment. 22. The apparatus according to Claim 21, wherein said containers are flexible plastic bags, said tubings are flexible plastic tubes, and said fluid flow control devices are slide clamps. 23. A method for the therapeutic treatment of a living body by applying thereto macrophages cultivates from blood. 24. The method according to Claim 23, wherein said macrophages are applied to a wound in the living body to promote wound healing. 25. The method according to either of Claims 23 or 24, wherein said macrophages are made by the method of any one of Claims 2-21.

Inventors: DANON DAVID, DANON, DAVID
Applicants: CROTTY DAPHNA, DANON DAVID, CROTTY, DAPHNA, DANON, DAVID
Application year: 1995
Main classification: A01N1
IPC codes: A01N1, A61K35, C12M1, C12M3, C12N5